These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23180244)

  • 1. Rv3080c regulates the rate of inhibition of mycobacteria by isoniazid through FabD.
    Kumari R; Saxena R; Tiwari S; Tripathi DK; Srivastava KK
    Mol Cell Biochem; 2013 Feb; 374(1-2):149-55. PubMed ID: 23180244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III activity is inhibited by phosphorylation on a single threonine residue.
    Veyron-Churlet R; Molle V; Taylor RC; Brown AK; Besra GS; Zanella-Cléon I; Fütterer K; Kremer L
    J Biol Chem; 2009 Mar; 284(10):6414-24. PubMed ID: 19074144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The R117A variant of the Escherichia coli transacylase FabD synthesizes novel acyl-(acyl carrier proteins).
    Marcella AM; Barb AW
    Appl Microbiol Biotechnol; 2017 Dec; 101(23-24):8431-8441. PubMed ID: 29075826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.
    Schaeffer ML; Agnihotri G; Volker C; Kallender H; Brennan PJ; Lonsdale JT
    J Biol Chem; 2001 Dec; 276(50):47029-37. PubMed ID: 11600501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The condensing activities of the Mycobacterium tuberculosis type II fatty acid synthase are differentially regulated by phosphorylation.
    Molle V; Brown AK; Besra GS; Cozzone AJ; Kremer L
    J Biol Chem; 2006 Oct; 281(40):30094-103. PubMed ID: 16873379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characterization of acyl carrier protein (AcpM) and malonyl-CoA:AcpM transacylase (mtFabD), two major components of Mycobacterium tuberculosis fatty acid synthase II.
    Kremer L; Nampoothiri KM; Lesjean S; Dover LG; Graham S; Betts J; Brennan PJ; Minnikin DE; Locht C; Besra GS
    J Biol Chem; 2001 Jul; 276(30):27967-74. PubMed ID: 11373295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate recognition by β-ketoacyl-ACP synthases.
    Borgaro JG; Chang A; Machutta CA; Zhang X; Tonge PJ
    Biochemistry; 2011 Dec; 50(49):10678-86. PubMed ID: 22017312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
    Slayden RA; Lee RE; Barry CE
    Mol Microbiol; 2000 Nov; 38(3):514-25. PubMed ID: 11069675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving fatty acid production in Escherichia coli through the overexpression of malonyl coA-acyl carrier protein transacylase.
    Zhang X; Agrawal A; San KY
    Biotechnol Prog; 2012; 28(1):60-5. PubMed ID: 22038854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis.
    Slayden RA; Barry CE
    Tuberculosis (Edinb); 2002; 82(4-5):149-60. PubMed ID: 12464486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function of heterologous Mycobacterium tuberculosis InhA, a type 2 fatty acid synthase enzyme involved in extending C20 fatty acids to C60-to-C90 mycolic acids, during de novo lipoic acid synthesis in Saccharomyces cerevisiae.
    Gurvitz A; Hiltunen JK; Kastaniotis AJ
    Appl Environ Microbiol; 2008 Aug; 74(16):5078-85. PubMed ID: 18552191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interfacial plasticity facilitates high reaction rate of
    Misson LE; Mindrebo JT; Davis TD; Patel A; McCammon JA; Noel JP; Burkart MD
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24224-24233. PubMed ID: 32929027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid.
    Mdluli K; Slayden RA; Zhu Y; Ramaswamy S; Pan X; Mead D; Crane DD; Musser JM; Barry CE
    Science; 1998 Jun; 280(5369):1607-10. PubMed ID: 9616124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA regulates mycolic acid biosynthesis.
    Veyron-Churlet R; Zanella-Cléon I; Cohen-Gonsaud M; Molle V; Kremer L
    J Biol Chem; 2010 Apr; 285(17):12714-25. PubMed ID: 20178986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.
    Unissa AN; Subbian S; Hanna LE; Selvakumar N
    Infect Genet Evol; 2016 Nov; 45():474-492. PubMed ID: 27612406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis.
    Vilchèze C; Morbidoni HR; Weisbrod TR; Iwamoto H; Kuo M; Sacchettini JC; Jacobs WR
    J Bacteriol; 2000 Jul; 182(14):4059-67. PubMed ID: 10869086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins.
    Bardou F; Quémard A; Dupont MA; Horn C; Marchal G; Daffé M
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2459-67. PubMed ID: 8913447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of Mycobacterium tuberculosis mtFabD, a malonyl-CoA:acyl carrier protein transacylase (MCAT).
    Ghadbane H; Brown AK; Kremer L; Besra GS; Fütterer K
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Oct; 63(Pt 10):831-5. PubMed ID: 17909282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of KasB regulates virulence and acid-fastness in Mycobacterium tuberculosis.
    Vilchèze C; Molle V; Carrère-Kremer S; Leiba J; Mourey L; Shenai S; Baronian G; Tufariello J; Hartman T; Veyron-Churlet R; Trivelli X; Tiwari S; Weinrick B; Alland D; Guérardel Y; Jacobs WR; Kremer L
    PLoS Pathog; 2014 May; 10(5):e1004115. PubMed ID: 24809459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PatA Regulates Isoniazid Resistance by Mediating Mycolic Acid Synthesis and Controls Biofilm Formation by Affecting Lipid Synthesis in Mycobacteria.
    Wang K; Deng Y; Cui X; Chen M; Ou Y; Li D; Guo M; Li W
    Microbiol Spectr; 2023 Jun; 11(3):e0092823. PubMed ID: 37212713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.